Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
Sponsor: ALX Oncology Inc.
Summary
A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma.
Official title: A Phase 2 Study of ALX148 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
189
Start Date
2021-04-02
Completion Date
2026-06-30
Last Updated
2025-08-01
Healthy Volunteers
No
Interventions
evorpacept
IV Q3W
pembrolizumab
IV Q3W
Locations (53)
Hoag Hospital
Irvine, California, United States
University of California San Diego
La Jolla, California, United States
H. Lee Moffitt Cancer Center
Tampa, Florida, United States
Northwest Georgia Oncology Centers
Marietta, Georgia, United States
Rush University Medical Center
Chicago, Illinois, United States
Blessing Cancer Center
Quincy, Illinois, United States
University of Maryland Medical System
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Rutgers Cancer Institute of New Jersey
Newark, New Jersey, United States
Memorial Sloan-Kettering Cancer Center
Long Island City, New York, United States
The Ohio State University
Columbus, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
Vanderbilt - Ingram Cancer Center
Nashville, Tennessee, United States
Houston Methodist Cancer Center
Houston, Texas, United States
St. Vincent's
Sydney, New South Wales, Australia
Royal Brisbane and Womens Hospital
Brisbane, Queensland, Australia
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
Ashford Cancer Centre Research
Windsor Gardens, Australia
Cliniques Universitaires Saint-Luc
Brussels, Belgium
AZ Groeninge
Kortrijk, Belgium
UZ Leuven
Leuven, Belgium
Hamilton Health Sciences - Juravinski Cancer Centre
Hamilton, Ontario, Canada
LHSC - Victoria Hospital
London, Ontario, Canada
Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
VUMC Goederenontvangst
Amsterdam, Netherlands
Universitair Medisch Centrum Groningen
Groningen, Netherlands
National University Cancer Institute
Singapore, Singapore
National Cancer Centre Singapore
Singapore, Singapore
Chungbuk National University Hospital
Cheongju-si, South Korea
Yeungnam University Medical Center
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
CHA University of Bundang
Gyeonggi-do, South Korea
Gachon University - Gil Medical Center
Incheon, South Korea
Seoul National University Bundang Hospital
Seongnam, South Korea
Korea University Medical Center (KUMC) - Korea University Anam Hospital
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
The Catholic University of Korea - Eunpyeong St. Mary's Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
SNU Boramae Medical Center
Seoul, South Korea
Severance Hospital Yonsei University
Seoul, South Korea
Catholic University of Korea, St. Vincent's Hospital Suwon
Suwon, South Korea
Yonsei University - Wonju Severance Christian Hospital
Wŏnju, South Korea
Hospital Universitari Dexeus
Barcelona, Barcelona, Spain
Institud Catala d´Oncologia
Barcelona, Spain
Hospital Universitario La Paz
Madrid, Spain
HM Sanchinarro
Madrid, Spain
Hospital Severo Ochoa
Madrid, Spain
Hospital Regional Universitario de Malaga
Málaga, Spain
Hospital Universitario de Navarra
Pamplona, Spain
Royal Marsden NHS Foundation Trust
London, United Kingdom
Royal Marsden NHS Foundation Trust
Sutton, United Kingdom